Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown. We previously determined, first, that metabolic endotoxemia controls the inflammatory tone, body weight gain, and diabetes, and second, that high-fat feeding modulates gut microbiota and the plasma concentration of lipopolysaccharide (LPS), i.e., metabolic endotoxemia. Therefore, it remained to demonstrate whether changes in gut microbiota control the occurrence of metabolic diseases. RESEARCH DESIGN AND METHODS—We changed gut microbiota by means of antibiotic treatment to demonstrate, first, that changes in gut microbiota could be responsible for the control of metabolic endotoxemia, the low-grade inflammation, obesity, and type 2 diabetes and, second, to provide some mechanisms responsible for such effect. RESULTS—We found that changes of gut microbiota induced by an antibiotic treatment reduced metabolic endotoxemia and the cecal content of LPS in both high-fat–fed and ob/ob mice. This effect was correlated with reduced glucose intolerance, body weight gain, fat mass development, lower inflammation, oxidative stress, and macrophage infiltration marker mRNA expression in visceral adipose tissue. Importantly, high-fat feeding strongly increased intestinal permeability and reduced the expression of genes coding for proteins of the tight junctions. Furthermore, the absence of CD14 in ob/ob CD14−/− mutant mice mimicked the metabolic and inflammatory effects of antibiotics. CONCLUSIONS—This new finding demonstrates that changes in gut microbiota controls metabolic endotoxemia, inflammation, and associated disorders by a mechanism that could increase intestinal permeability. It would thus be useful to develop strategies for changing gut microbiota to control, intestinal permeability, metabolic endotoxemia, and associated disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacterial translocation can be defined as the passage of bacteria, or bacterial products such as LPS, into the portal circulation and happens when the complex regulation of the mechanisms of the gut barrier is lost [276], which has been linked with the occurrence of NAFLD, NASH, hepatic fibrosis, and HCC in several rodent models [227,228,277].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [276]
In the citing paper
“Penetration of lipopolysaccharide into the bloodstream is controlled by the integrity of the gut barrier.”
From Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice (2016) · cites this paper as [48]
In the citing paper
“In obese rodents, antibiotics and prebiotics were able to restore gut barrier integrity and metabolic functions, providing evidence for the gut barrier as a mediator of microbiota-induced systemic inflammation [98,99].”
Citations
Cites
1 retracted
Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araújo, E. P., Vassallo, J., Curi, R., Velloso, L. A., et al. (2007) · Diabetes · doi:10.2337/db06-1595 · Cited by 826 · cited 3×
“We and others have recently demonstrated that the mechanisms of highfat diet-induced inflammation and metabolic disorders were clearly linked to LPS (4;24-28).”
BackgroundResultRetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 7×
“Inflammation: PAI-1, IL-1, and TNF- mRNA concentrations (A, D and G); oxidative stress: STAMP-2 and NADPHox mRNA concentrations (B and E); macrophage infiltration markers: MCP-1 and F4/80 mRNA concentrations (C and F) in mice fed normal diet (CT), normal diet and antibiotics (CT-Ab), high-fat diet (HF), or high-fat di…”
ResultInfluentialInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown (2,3).”
BackgroundHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 2×
“Gut microbiota has recently been proposed as an environmental factor involved in the control of body weight and energy homeostasis (7-12).”
BackgroundResultMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 16×
“Although the reasons for its increase in plasma during high-fat feeding were undetermined, its levels were closely correlated but not causatively demonstrated, with changes in intestinal microbiota where the Gram negative–to–Gram positive ratio increased during high-fat feeding (4).”
BackgroundMethodResultSelf-citationThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Germ-free mice of the same age and genetic background as conventional mice fed with a normal chow diet had a 40% lower weight (11), whereas germ-free mice colonized with the gut microbiota derived from the conventional mice increased their fat mass and developed insulin resistance within 2 weeks.”
BackgroundObesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“These animals are characterized by different gut microbiota (8,12), higher inflammatory tone, and endotoxemia when compared with wild-type mice (23).”
BackgroundIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“Oxidative stress is frequently associated with inflammation and metabolic dysfunction in adipose depots (20-22).”
BackgroundMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Diabetes 57:1470–1481, 2008 Environmental factors, such as a fat-enriched diet and a sedentary lifestyle, are the causes of the great prevalence of obesity and type 2 diabetes in the population (1).”
Background
Cited by
Items 801–900 of 1,065
Mani, V., Hollis, J. H., & Gabler, N. K. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-6 · Cited by 131
“In recent years, the development of obesity, inflammation, atherosclerosis and other metabolic diseases has been linked to low grade endotoxemia associated with high dietary fat and energy intake [3,14,28-30].”
BackgroundInfluentialPhytosterols: Nutritional Health Players in the Management of Obesity and Its Related Disorders
Vezza, T., Canet, F., Marañón, A., Bañuls, C., Rocha, M., & Víctor, V. M. (2020) · Antioxidants · doi:10.3390/antiox9121266 · Cited by 150
Ecklu-Mensah, G., Choo-Kang, C., Maseng, M. G., Donato, S., Bovet, P., Viswanathan, B., Bedu-Addo, K., Plange‐Rhule, J., Boateng, P. O., Forrester, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40874-x · Cited by 156
Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder
Luqman, A., Hassan, A., Ullah, M., Naseem, S., Ullah, M., Zhang, L., Din, A. U., Ullah, K., Ahmad, W., & Wang, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1321395 · Cited by 157
“This impact can alter a variety of bodily processes, including immunological control, metabolism, and ultimately general health (48, 234 – 237 ).”
BackgroundReigstad, C. S., Lundén, G. Ö., Felin, J., & Bäckhed, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005842 · Cited by 131
“Obesity and the metabolic syndrome are associated with low-grade ‘metabolic’ inflammation [10] and recent data suggest that lipopolysaccharide (LPS) derived from the gut microbiota contributes to the increased development of adipose tissue and impaired glucose tolerance [11,12].”
Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease
Hernandez-Rodas, M., Valenzuela, R., & Videla, L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025168 · Cited by 130
“Under these conditions, NAFLD underlying lipid accumulation and increased portal plasma lipopolysaccharide (LPS) concentrations, resulted in derangement of intestinal barrier functions, as evidenced by depressed expression of the tight-junction protein occluding and the serotonin re-uptake transporter (SERT), changes…”
BackgroundInfluentialNonalcoholic fatty liver disease as a multi-systemic disease
Fotbolcu, H., & Zorlu, E. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i16.4079 · Cited by 130
Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease
Vrakas, S., Mountzouris, K. C., Michalopoulos, G., Karamanolis, G., Papatheodoridis, G., Tzathas, C., & Gazouli, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170034 · Cited by 130
Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders
Farzaei, M. H., Singh, A. K., Kumar, R., Croley, C. R., Pandey, A. K., Coy-Barrera, E., Kumar Patra, J., Das, G., Kerry, R. G., Annunziata, G., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194957 · Cited by 129
Wewalka, M., Patti, M.-E., Barbato, C., Houten, S. M., & Goldfine, A. B. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3367 · Cited by 129
Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond
Cani, P. D., Geurts, L., Matamoros, S., Plovier, H., & Duparc, T. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.02.004 · Cited by 156
Self-citationPedersen, R., Ingerslev, H.-C., Sturek, M., Alloosh, M., Cirera, S., Christoffersen, B. Ø., Moesgaard, S. G., Larsen, N., & Boye, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056612 · Cited by 129
“In addition, Cani and colleagues [13–15] have provided evidence of a causal role of gut microbiota in the low grade inflammation in the gut of mice.”
Rodrigues, R. R., Greer, R. L., Dong, X., DSouza, K. N., Gurung, M., Wu, J. Y., Morgun, A., & Shulzhenko, N. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02306 · Cited by 129
“…have some discrepancies with our observations, there are numerous supportive studies using germ-free (Caesar et al., 2012) or diet-induced obese (Cani et al., 2008, 2014; Membrez et al., 2008; Carvalho et al., 2012; Hwang et al., 2015; Fujisaka et al., 2016) mice that have shown improved…”
ResultGohir, W., Kennedy, K. M., Wallace, J. G., Saoi, M., Bellissimo, C. J., Britz‐McKibbin, P., Petrik, J., Surette, M. G., & Sloboda, D. M. (2019) · The Journal of Physiology · doi:10.1113/jp277353 · Cited by 141
“2016), comprising decreases that have been associated with endotoxaemia in male HFD mice (Cani et al. 2008).”
BackgroundModulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes
Huda, M. N., Kim, M., & Bennett, B. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.632335 · Cited by 142
Impacts of essential amino acids on energy balance
Xiao, F., & Guo, F. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101393 · Cited by 127
“Changes of gut microbiota induced by an antibiotic treatment could reduce adipose tissue inflammation in HFD-fed mice [86].”
BackgroundRajkumar, H., Kumar, M., Das, N., Kumar, S. N., Challa, H. R., & Nagpal, R. (2015) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414555004 · Cited by 128
“Email: manoj15micro@yahoo.co.in metabolism and function and also influences the development of obesity and related metabolic diseases.14,15 Studies have revealed a close relationship between metabolic and inflammatory pathways, with inflammation playing an important role in obesity and metabolic diseases such as insul…”
BackgroundInfluentialChronic Low-Grade Inflammation in Metabolic Disorders: Relevance for Behavioral Symptoms
Lasselin, J., & Capuron, L. (2014) · Neuroimmunomodulation · doi:10.1159/000356535 · Cited by 128
Rial, S., Karelis, A., Bergeron, K.-F., & Mounier, C. (2016) · Nutrients · doi:10.3390/nu8050281 · Cited by 127
Gut Microbiome in Obesity, Metabolic Syndrome, and Diabetes
Chen, X., & Devaraj, S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1104-3 · Cited by 136
Molecular Mechanism Responsible for the Priming of Macrophage Activation
Deng, H., Maitra, U., Morris, M., & Li, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.424390 · Cited by 128
Mathur, R., Amichai, M., Chua, K. S., Mirocha, J., Barlow, G. M., & Pimentel, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3144 · Cited by 126
“Intestinal flora have been implicated in many mechanisms that may contribute to weight gain, including enhanced lipopolysaccharide production leading to insulin resistance (5), suppression of fasting-induced adipose factor (14), suppression of AMP-activated protein kinase-driven fatty acid oxidation in the liver (15),…”
BackgroundAmyot, J., Semache, M., Ferdaoussi, M., Fontés, G., & Poitout, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036200 · Cited by 127
“which express lipopolysaccharides (LPS). This is associated with increased circulating levels of LPS and low-grade endotoxemia which plays a role, at least in part, in the onset of metabolic diseases. In support of this, modulation of the gut microflora in rodents reduces circulating levels of LPS and protects from di…”
BackgroundOntogenetic Differences in Dietary Fat Influence Microbiota Assembly in the Zebrafish Gut
Wong, S., Stephens, W. Z., Burns, A. R., Stagaman, K., David, L. A., Bohannan, B. J. M., Guillemin, K. J., & Rawls, J. F. (2015) · mBio · doi:10.1128/mbio.00687-15 · Cited by 137
Chen, Y., Xu, C., Huang, R., Song, J., Li, D., & Xia, M. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.02.011 · Cited by 137
Effect of Vitamin D Supplementation on Faecal Microbiota: A Randomised Clinical Trial
Naderpoor, N., Mousa, A., Gómez-Arango, L. F., Barrett, H. L., Nitert, M. D., & de Courten, B. V. (2019) · Nutrients · doi:10.3390/nu11122888 · Cited by 141
Singh, A., D’Amico, D., Andreux, P. A., Dunngalvin, G., Kern, T., Blanco-Bose, W., Auwerx, J., Aebischer, P., & Rinsch, C. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00950-1 · Cited by 124
Early life events influence whole-of-life metabolic health via gut microflora and gut permeability
Kerr, C. A., Grice, D. M., Tran, C. D., Bauer, D. C., Li, D., Hendry, P., & Hannan, G. N. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.837863 · Cited by 126
“However, changes in microbial resilience and diversity are observed in disease states (Cani et al., 2008; Turnbaugh & Gordon, 2009; Vaarala et al., 2008).”
BackgroundMolecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
Takaki, A., Kawai, D., & Yamamoto, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15057352 · Cited by 126
“Plasma endotoxin levels are significantly higher in patients with NAFLD and in murine NASH models [27,28].”
BackgroundNikbakht, E., Khalesi, S., Singh, I., Williams, L. T., West, N. P., & Colson, N. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1300-3 · Cited by 126
“The accompanying inflammatory state, which is metabolic endotoxemia, may be associated with insulin resistance and weight gain [11, 14].”
BackgroundEmbracing the gut microbiota: the new frontier for inflammatory and infectious diseases
van den Elsen, L. W., Poyntz, H. C., Weyrich, L. S., Young, W., & Forbes‐Blom, E. E. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2016.91 · Cited by 126
Mukherjee, S., Joardar, N., Sengupta, S., & Sinha Babu, S. P. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.07.010 · Cited by 124
“breakdown of microbial communities, has been implicated as a cause for several acute and chronic problems such as inflammatory bowel disease, irritable bowel syndrome, metabolic diseases such as obesity, diabetes, allergic diseases, neuro-developmental illness and life-threatening infectious diseases ranging from micr…”
BackgroundVildagliptin increases butyrate-producing bacteria in the gut of diabetic rats
Zhang, Q., Xiao, X., Li, M., Yu, M., Ping, F., Zheng, J., Wang, T., & Wang, X. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184735 · Cited by 124
Physiology and pathophysiology of liver lipid metabolism
Ponziani, F. R., Pecere, S., Gasbarrini, A., & Ojetti, V. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1056156 · Cited by 147
“Antibiotics reduce metabolic endotoxemia, the accumulation of fat in the liver and inflammation [137,138].”
BackgroundMurakami, Y., Tanabe, S., & Suzuki, T. (2016) · Journal of Food Science · doi:10.1111/1750-3841.13166 · Cited by 125
Brain–Gut–Bone Marrow Axis: Implications for Hypertension and Related Therapeutics
Santisteban, M. M., Kim, S., Pepine, C. J., & Raizada, M. K. (2016) · Circulation Research · doi:10.1161/circresaha.116.307709 · Cited by 126
“Gut dysbiosis has been classically associated with increased intestinal inflammation and enhanced barrier permeability in animal models of obesity and diabetes mellitus.(86,87)”
BackgroundSingh, S., Sharma, R. K., Malhotra, S., Pothuraju, R., & Shandilya, U. K. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0090 · Cited by 124
Gut Microbiota in Health and Disease
Yamashiro, Y. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000481627 · Cited by 144
Microbiome and diabetes: Where are we now?
Vallianou, N. G., Stratigou, T., & Tsagarakis, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.008 · Cited by 138
Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease
Donath, M. Y., Meier, D. T., & Böni-Schnetzler, M. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00002 · Cited by 124
The gut microbiome regulates host glucose homeostasis via peripheral serotonin
Martin, A. M., Yabut, J. M., Choo, J. M., Page, A. J., Sun, E. W. L., Jessup, C. F., Wesselingh, S. L., Khan, W. I., Rogers, G. B., Steinberg, G. R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909311116 · Cited by 137
“5 g/L neomycin; Sigma) to induce a dysbiosis model (20, 21) or on control water for 28 d.”
MethodLiu, S., Yu, H., Li, P., Wang, C., Liu, G., Zhang, X., ZHANG, C., Qi, M., & Ji, H. (2021) · Animal nutrition · doi:10.1016/j.aninu.2021.07.001 · Cited by 133
“Highfat diet can cause intestinal inflammation and increased TNF-a, IL-1, and IL-6 mRNA expression levels in mice (Cani et al., 2008; MoranRamos et al., 2017).”
BackgroundThe potential of probiotics in the amelioration of hyperuricemia
Zhao, H., Lu, Z., & Lu, Y. (2022) · Food & Function · doi:10.1039/d1fo03206b · Cited by 133
Obesity-induced inflammation: connecting the periphery to the brain
Le Thuc, O., & García-Cáceres, C. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01079-8 · Cited by 125
“…tissue associated with obesity 113, 140, 141 Hypercaloric diet induces endotoxaemia, increased gut permeability and changes in the microbiota 28, 142 Other immune cell types participate in adipose tissue inflammation associated with obesity 143–145 Obesity also associated with higher…”
Probiotics, prebiotics, and the host microbiome: the science of translation
Petschow, B., Doré, J., Hibberd, P., Dinan, T., Reid, G., Blaser, M., Cani, P. D., Degnan, F. H., Foster, J., Gibson, G., et al. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12303 · Cited by 124
Self-citationThe Gut Microbiome as a Target for the Treatment of Type 2 Diabetes
Aydin, Ö., Nieuwdorp, M., & Gerdes, V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1020-6 · Cited by 124
Okuno, Y., Fukuhara, A., Hashimoto, E., Kobayashi, H., Kobayashi, S., Otsuki, M., & Shimomura, I. (2018) · Diabetes · doi:10.2337/db17-1032 · Cited by 124
“Many studies have suggested that Fat ROS are involved in various pathways in metabolic syndrome, including adipocyte insulin signaling (12), adipose inflammation (8), endoplasmic reticulum stress (13), mitochondrial function (14), cellular senescence (15), gut microbiota (16), adiponectin (Adipoq) (8), adiponectin rec…”
BackgroundMetagenome and metabolism: the tissue microbiota hypothesis
Burcelin, R., Serino, M., Chabo, C., Garidou, L., Pomié, C., Courtney, M., Amar, J., & Bouloumié, A. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12157 · Cited by 124
“The former hypothesis is supported by data showing that the origin of the metabolic endotoxemia could be linked to an increased proliferation of Gram-negative bacteria, notably proteobacteria [30,51].”
BackgroundSelf-citationHigh fat diet drives obesity regardless the composition of gut microbiota in mice
Rabot, S., Membrez, M., Blancher, F., Berger, B., Moine, D., Krause, L., Bibiloni, R., Bruneau, A., Gérard, P., Siddharth, J., et al. (2016) · Scientific Reports · doi:10.1038/srep32484 · Cited by 125
“For example, endotoxemia resulting from bacterial LPS induced inflammatory response has been associated with insulin resistance in DIO mice 36,37 .”
Self-citationNonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective
Bauer, K. C., Littlejohn, P. T., Ayala, V., Creus-Cuadros, A., & Finlay, B. B. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.01.058 · Cited by 139
Inflammation‐mediated metabolic regulation in adipose tissue
Xu, S., Lu, F., Gao, J., & Yuan, Y. (2024) · Obesity Reviews · doi:10.1111/obr.13724 · Cited by 151
“74,75 This suggests that adipose inflammation is not simply the outcome of the metabolic disease itself but may be the result of interactions between changes in the intestinal microbiota, the metabolic dysregulation of adipose tissue, and immune system activation.”
BackgroundAnti-obesity effects of gut microbiota are associated with lactic acid bacteria
Tsai, Y.-T., Cheng, P.-C., & Pan, T. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5346-3 · Cited by 133
Ferguson, J. F., Allayee, H., Gerszten, R. E., Ideraabdullah, F., Kris-Etherton, P. M., Ordovás, J. M., Rimm, E. B., Wang, T. J., & Bennett, B. J. (2016) · Circulation: Cardiovascular Genetics · doi:10.1161/hcg.0000000000000030 · Cited by 123
Strain-level dissection of the contribution of the gut microbiome to human metabolic disease
Zhang, C., & Zhao, L. (2016) · Genome Medicine · doi:10.1186/s13073-016-0304-1 · Cited by 123
“Removal of gut microbiota by using cocktails of broad-spectrum antibiotics prevented fat accumulation even in genetically obese mice, such as ob/ob mice or Toll-like receptor 5 knockout mice [10, 11].”
BackgroundProbiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism?
Park, C., Brietzke, E., Rosenblat, J. D., Musial, N., Zuckerman, H., Ragguett, R.-M., Pan, Z., Rong, C., Fus, D., & McIntyre, R. S. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.07.006 · Cited by 123
The role of the gut microbiota in health and cardiovascular diseases
Wang, L., Wang, S., Zhang, Q., He, C., Fu, C., & Wei, Q. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00091-2 · Cited by 122
Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature
Pijls, K. E., Jonkers, D. M. A. E., Elamin, E. E., Masclee, A., & Koek, G. H. (2013) · Liver International · doi:10.1111/liv.12271 · Cited by 137
“The association between intestinal microbiota, intestinal epithelial barrier function and obesity is further supported by intervention studies in mice, showing that modulation of the intestinal microbiota composition with prebiotic and/or antibiotic treatment improved intestinal permeability, changed expression of TJ…”
BackgroundObesity and Metabolic Syndrome: An Inflammatory Condition
Scarpellini, E., & Tack, J. (2012) · Digestive Diseases · doi:10.1159/000336664 · Cited by 122
Grams, J. M., & Garvey, W. T. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0155-x · Cited by 146
The gut microbiome in cardio-metabolic health
Hansen, T. H., Gøbel, R. J., Hansen, T., & Pedersen, O. (2015) · Genome Medicine · doi:10.1186/s13073-015-0157-z · Cited by 122
“These effects appear to be mediated by increased release of the anorexigenic gut hormones GLP-1, GLP-2 and PYY [70,113,114,116,118], by reduced release of the orexigenic peptide ghrelin [114,118-120], and by reducing endotoxemia by way of improved mucosal barrier function, thus reducing levels of inflammatory markers…”
BackgroundLee, S.-M., Han, H. W., & Yim, S. Y. (2015) · Food & Function · doi:10.1039/c4fo00731j · Cited by 122
The role of sodium in modulating immune cell function
Wilck, N., Balogh, A., Markó, L., Bartolomaeus, H., & Müller, D. N. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0167-y · Cited by 136
Bai, Y., Wang, S., Wang, X., Weng, Y., Fan, X., Sheng, H., Zhu, X.-T., Lou, L.-J., & Zhang, F. (2019) · Nutrition and Diabetes · doi:10.1038/s41387-019-0097-6 · Cited by 129
Alemany-Cosme, E., González, E. S., Moret, I., Mateos, B., Iborra, M., Nos, P., Sandoval, J., & Beltrán, B. (2021) · Antioxidants · doi:10.3390/antiox10010064 · Cited by 148
“Previous studies (also conducted in mice) already indicated that a diet high in fat and sugars induces dysbiosis in the mucosa microbiota and is associated with a less protective mucosal layer and increased permeability, which can result in low-grade inflammation and metabolic disorders [82,83].”
BackgroundShared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease
Nordestgaard, L. T., Christoffersen, M., & Frikke‐Schmidt, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179777 · Cited by 141
Chu, W., Han, Q., Xu, J., Wang, J., Sun, Y., Li, W., Chen, Z.-J., & Du, Y. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.01.027 · Cited by 121
Dahiya, D., & Nigam, P. S. (2022) · Microorganisms · doi:10.3390/microorganisms10030665 · Cited by 122
“The gut microbiota alters the micro-ecological structure of the host gut, reduces LPS-producing Gram-negative bacterial strains, and increases the population of SCFAproducing strains [78,79], facilitating farnesoid X receptor (FXR) signaling for the regulation of the bile acid metabolism [80], regulating the secretion…”
BackgroundMannan-oligosaccharide modulates the obesity and gut microbiota in high-fat diet-fed mice
Wang, H., Zhang, X., Wang, S., Li, H., Lu, Z., Shi, J., & Xu, Z. (2018) · Food & Function · doi:10.1039/c8fo00209f · Cited by 120
Liu, H., Zhang, M., Ma, Q., Tian, B., Nie, C., Chen, Z., & Li, J. (2020) · Food & Function · doi:10.1039/d0fo00855a · Cited by 136
The Role of Catechins in Regulating Diabetes: An Update Review
Wen, L., Wu, D., Tan, X., Zhong, M., Xing, J., Li, W., Li, D., & Cao, F. (2022) · Nutrients · doi:10.3390/nu14214681 · Cited by 144
“, lipopolysaccharide (LPS)) into circulation, causing tissue damage and a systemic inflammatory response, ultimately inducing insulin resistance [137].”
BackgroundGruber, L., Kisling, S., Lichti, P., Martin, F., May, S., Klingenspor, M., Lichtenegger, M., Rychlik, M., & Haller, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071661 · Cited by 134
“Studies on the effect of HFD in the large intestine have previously shown a loss of colonic Occludin expression [24,25].”
BackgroundLeber, B., Tripolt, N. J., Blattl, D., Eder, M., Wascher, T. C., Pieber, T. R., Stauber, R. E., Sourij, H., Oettl, K., & Stadlbauer, V. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.103 · Cited by 138
Seo, D.-B., Jeong, H. W., Cho, D., Lee, B. J., Lee, J. H., Choi, J. Y., Bae, I.-H., & Lee, S.-J. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3265 · Cited by 120
“2 7 For instance, the diversity of the gut microbiota reflects the metabolic status of the host.”
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis
Ghetti, F. D. F., de Oliveira, D. G., de Oliveira, J. M., Ferreira, L. E. V. V. D. C., Cesar, D. E., & Moreira, A. P. B. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1524-x · Cited by 130
“It has been proposed that changes in the gut microbiota favor an increase in circulatory lipopolysaccharides (LPS), particularly when the diets are rich in fat and energy [89, 90].”
BackgroundRittiphairoj, T., Pongpirul, K., Janchot, K., Mueller, N. T., & Li, T. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa133 · Cited by 144
Gao, X., Chang, S., Liu, S., Peng, L., Xie, J., Dong, W., Tian, Y., & Sheng, J. (2020) · mSystems · doi:10.1128/msystems.00391-20 · Cited by 133
Impaired Intestinal Barrier and Tissue Bacteria: Pathomechanisms for Metabolic Diseases
Massier, L., Blüher, M., Kovacs, P., & Chakaroun, R. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.616506 · Cited by 119
“Pussinen et al. analyzed LPS levels of patients with prevalent (n=537) and incident T2D (n=462) and compared them to a control group (n=6,170), of which about 20% had the metabolic syndrome.”
BackgroundInfluentialWang, J., Bose, S., Kim, G.-C., Hong, S.-U., Kim, J.-H., Kim, J.-E., & Kim, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086117 · Cited by 127
“It has been found that the exposure to LPS may directly or indirectly cause destabilization of intestinal barrier function leading to an augmentation of gut permeability [12,49].”
BackgroundInfluentialThe Effect of Bariatric Surgery on Intestinal Absorption and Transit Time
Carswell, K. A., Vincent, R. P., Belgaumkar, A. P., Sherwood, R. A., Amiel, S. A., Patel, A. G., & le Roux, C. W. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1166-x · Cited by 130
“We did not measure gut flora in the present study, and changes in these can alter gut permeability [86].”
BackgroundMicrobial Translocation in Chronic Liver Diseases
Pinzone, M. R., Celesia, B. M., Rosa, M. D., Cacopardo, B. S., & Nunnari, G. (2012) · International Journal of Microbiology · doi:10.1155/2012/694629 · Cited by 129
“A high-fat diet has been reported not only to increase intestinal translocation of endotoxin in mice (the so-called metabolic endotoxemia), but also to reduce enteric Bifidobacteria [93, 94], a group of bacteria that have been shown to lower intestinal LPS levels and to improve mucosal barrier function [95].”
BackgroundVolynets, V., Reichold, A., Bárdos, G., Rings, A., Bleich, A., & Bischoff, S. C. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3935-y · Cited by 137
Cires, M. J., Wong, X., Carrasco‐Pozo, C., & Gotteland, M. (2017) · Frontiers in Nutrition · doi:10.3389/fnut.2016.00057 · Cited by 134
Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure
Jia, Q., Li, H., Zhou, H., Zhang, X., Zhang, A., Xie, Y., Li, Y., Lv, S., & Zhang, J. (2019) · Cardiovascular Therapeutics · doi:10.1155/2019/5164298 · Cited by 129
Kanazawa, A., Aida, M., Yoshida, Y., Kaga, H., Katahira, T., Suzuki, L., Tamaki, S., Sato, J., Goto, H., Azuma, K., et al. (2021) · Nutrients · doi:10.3390/nu13020558 · Cited by 140
Juricic, P., Lu, Y.-X., Leech, T., Drews, L. F., Paulitz, J., Lu, J., Nespital, T., Azami, S., Regan, J. C., Funk, E., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00278-w · Cited by 118
Gut Microbiota and the Pathogenesis of Insulin Resistance
Delzenne, N. M., & Cani, P. D. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0191-1 · Cited by 134
“In fact, the endotoxemia remains quite modest (the concentration of LPS is approximately doubled in obesity), but when reproduced by chronic injection of exogenous LPS, is able to reproduce the loss of insulin sensitivity present in the obese mice [14, 15].”
BackgroundSelf-citationHsieh, F.-C., Lan, C.-C. E., Huang, T.-Y., Chen, K.-W., Chai, C.-Y., Chen, W.-T., Fang, A.-H., Chen, Y.-H., & Wu, C.-S. (2016) · Food & Function · doi:10.1039/c5fo01396h · Cited by 118
Rodrigues, M. E. D. S., Bekhbat, M., Houser, M. C., Chang, J., Walker, D. I., Jones, D. P., do Nascimento, C. M. P. O., Barnum, C. J., & Tansey, M. G. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.08.021 · Cited by 128
“These findings are in line with previous data that implicate increased gut permeability and endotoxemia as triggers for maladaptive immune responses present in obesity (Cani et al., 2008; Moreira et al., 2012).”
ResultNishitsuji, K., Xiao, J., Nagatomo, R., Umemoto, H., Morimoto, Y., Akatsu, H., Inoue, K., & Tsuneyama, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-16189-5 · Cited by 118
Elucidation of Akkermansia muciniphila Probiotic Traits Driven by Mucin Depletion
Shin, J., Noh, J., Chang, D., Kim, Y., Kim, M. H., Lee, E. S., Cho, S., Ku, B. J., Rhee, M.-S., Kim, B., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01137 · Cited by 133
“increase the expression of pro-inflammatory cytokines in the gut (Cani et al., 2008), and some cytokines can directly influence goblet cell function.”
BackgroundLiu, Y., Wang, C., Li, J., Li, T., Zhang, Y., Liang, Y., & Mei, Y. (2019) · The FASEB Journal · doi:10.1096/fj.201901943rr · Cited by 128
Gut microbiota and old age: Modulating factors and interventions for healthy longevity
Coman, V., & Vodnar, D. C. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111095 · Cited by 118
“In turn, changes in gut microbiota can increase intestinal permeability while affecting metabolic endotoxemia, inflammation, and insulin sensitivity (Cani et al., 2007; Cani et al., 2008).”
Diet, microbiota, and the mucus layer: The guardians of our health
Suriano, F., Nyström, E. E. L., Sergi, D., & Gustafsson, J. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953196 · Cited by 136
Moreno‐Navarrete, J. M., Escoté, X., Ortega, F. J., Sérino, M., Campbell, M., Michalski, M., Laville, M., Xifra, G., Luche, É., Domingo, P., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3015-9 · Cited by 125
“They were approved by the local ethics committee of the Rangueil Hospital, Toulouse, France and were performed as previously described [4, 18, 25, 26].”
MethodSelf-citationCani, P. D. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03866.x · Cited by 128
“However, various situations (stress, alcohol consumption, fat intake) have been described to alter this protective function leading to a leaky gut (and thereby promoting metabolic endotoxaemia) [9–13].”
BackgroundSelf-citationGut microbiota and obesity: Role in aetiology and potential therapeutic target
Moran, C. P., & Shanahan, F. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.07.005 · Cited by 138
Lactulose Differently Modulates the Composition of Luminal and Mucosal Microbiota in C57BL/6J Mice
Mao, B., Li, D., Ai, C., Zhao, J., Zhang, H., & Chen, W. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b02305 · Cited by 118
Pedersen, C., Gallagher, E., Horton, F., Ellis, R. J., Ijaz, U. Z., Wu, H., Jaiyeola, E., Diribe, O., Duparc, T., Cani, P. D., et al. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516004086 · Cited by 117
“Other medications (n) used by patients in the prebiotic group were statins (11), blood pressure medication (8), fenofibrate (2), omeprazole (2), low-dose aspirin (1), levothyroxine sodium (1) and citalopram (1).”
Self-citationAtorvastatin Treatment Modulates the Gut Microbiota of the Hypercholesterolemic Patients
Khan, T. J., Ahmed, Y. M., Zamzami, M. A., Siddiqui, A. M., Khan, I., Baothman, O. A. S., Mehanna, M. G., Kuerban, A., Mohammed, K., & Yasir, M. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0130 · Cited by 125
“In recent years, GM has emerged as a new regulatory factor in disorders such as obesity, diabetes, and atherosclerosis (Cani et al., 2008; Fei and Zhao, 2013; Koren et al., 2011; Turnbaugh et al., 2006).”
Esgalhado, M., Kemp, J. A., Azevedo, R., Paiva, B. R., Stockler‐Pinto, M. B., Dolenga, C. J. R., Borges, N. A., Nakao, L. S., & Mafra, D. (2018) · Food & Function · doi:10.1039/c8fo01876f · Cited by 124
Metadata
- Authors
- Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R.
- Affiliations
- UCLouvain (BE)
- Nestlé (Switzerland) (CH)
- Rangueil Institute of Molecular Medicine, Toulouse, France
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-06-01
- Volume
- 57
- Issue
- 6
- Pages
- 1470-1481
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2129917444
- Cited by
- 4,819
- References
- 47
- Citations by year
- 2026: 223 · 2025: 240 · 2024: 305 · 2023: 319 · 2022: 397 · 2021: 420 · 2020: 389 · 2019: 396 · 2018: 368 · 2017: 319 · 2016: 319 · 2015: 292 · 2014: 199 · 2013: 187 · 2012: 149
- FWCI
- 40.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Digital Access to Libraries (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-05-PNRA-004, ANR-05)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- gut microbiota, metabolic endotoxemia, lipopolysaccharide, high-fat diet, obesity, type 2 diabetes, low-grade inflammation, antibiotic therapy, intestinal permeability, tight junctions, CD14, visceral adipose tissue, oxidative stress, impaired glucose tolerance, ob/ob mice
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteroides, Base Sequence, Bifidobacterium, Cecum, Crosses, Genetic, Diabetes Mellitus, Experimental, Feces, Female, Genotype, Inflammation, Lactobacillus, Male, Mice, Inbred C57BL, Mice, Obese, Obesity, RNA, Bacterial, Endotoxemia, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.